DOI QR코드

DOI QR Code

Development of Clotrimazole Gels for Enhanced Transdermal Delivery

  • Cho, Hwa-Young (College of Pharmacy, Chonnam National University) ;
  • Kim, Dal-Keun (College of Pharmacy, Chonnam National University) ;
  • Park, ung-Chan (College of Pharmacy, Chonnam National University) ;
  • Kang, Chung (College of Pharmacy, Chonnam National University) ;
  • Oh, In-Joon (College of Pharmacy, Chonnam National University) ;
  • Kim, Seong-Jin (School of Medicine, Chonnam National University) ;
  • Shin, Sang-Chu (College of Pharmacy, Chonnam National University)
  • Published : 2009.12.20

Abstract

To develop a topical bioadhesive formulation of clotrimazole for enhanced transdermal delivery, hydroxypropyl methylcellulose gel containing permeation enhancer was formulated and permeation studies were carried out. The release characteristics of the drug from the gel formulation were examined according to the receptor medium, drug concentration, and temperature. The rate of drug release from the gel increased with increasing drug concentration and temperature. The activation energy (Ea) of drug permeation, which was calculated from the slope of log P versus 1/T plots, was 14.41kcal/mol for a 1%(w/w) loading dose. The enhancer, such as saturated, unsaturated fatty acids, pyrrolidones, propylene glycol derivatives, glycerides, and non-ionic surfactants, were incorporated onto the gels to increase the amount of drug permeation into the skin. Among the enhancers used, polyoxyethylene 2-oleyl ether showed the highest level of enhancement. These results show that clotrimazole gels containing polyoxyethylene 2-oleyl ether could be used for the enhanced transdermal delivery of clotrimazole.

Keywords

References

  1. M.O.Ahmed, I. El-Gibaly and S.M.Ahmed, Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole. Int. J. Pharm., 171, 111-121 (1998). https://doi.org/10.1016/S0378-5173(98)00163-X
  2. J.S.Yuan, M.Ansari, M.Samaan and E.J.Acosta, Linker-based lecithin microemulsions for transdermal delivery of lidocaine. Int. J. Pharm., 349, 130-143 (2008). https://doi.org/10.1016/j.ijpharm.2007.07.047
  3. B.M. Magnusson and P. Runn, Effect of penetration enhancerson the permeation of the thyrotropin releasing hormone analogue pGlu-3-methyl-His-Pro amide through human epidermis. Int. J. Pharm., 178, 149-159 (1997). https://doi.org/10.1016/S0378-5173(98)00316-0
  4. T. Ghafourian, P. Zandasrar, H. Hamishekar and A. Nokhodchi, The effect of penetration enhancers on drug delivery through skin: a QSAR study. J. Cont. Rel., 99, 113-125 (2004). https://doi.org/10.1016/j.jconrel.2004.06.010
  5. A.F. El-Kattan, C.S. Asbill and B.B. Michniak, The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm., 198, 179-189 (2000). https://doi.org/10.1016/S0378-5173(00)00330-6
  6. S. Miyazaki, S. Takeuchi, C. Yokouchi and M. Takada, Pluronic F-127 gels as a vehicle for topical administration of anticancer agents. Chem. Pharm. Bull., 32, 4205-4208 (1984). https://doi.org/10.1248/cpb.32.4205
  7. Y.W. Chien and E.P. K.Lau, Controlled drug release from polymeric delivery devices IV:In vitro-in vivo correlation of subcutaneous release of norgestomet from hydrophilic implants. J. Pharm. Sci., 65, 488-494 (1976). https://doi.org/10.1002/jps.2600650404
  8. R.B. Walker and E.W. Smith, The role of percutaneous penetration enhancers. Adv. Drug Del. Rev., 18, 295-301 (1996). https://doi.org/10.1016/0169-409X(95)00078-L
  9. A.C. Williams and B.W. Barry, Penetration enhancers. Adv. Drug Del. Rev., 56, 603-618 (2004). https://doi.org/10.1016/j.addr.2003.10.025
  10. E.M. Niazy, Influence of oleic acid and other permeation promoters on transdermal delivery of dihydroergotamine through rabbit skin. Int. J. Pharm., 67, 97-100 (1991). https://doi.org/10.1016/0378-5173(91)90269-T
  11. D. Lewis and J. Hadgraft, Mixed monolayers of dipalmitoyl phosphatidylcholine with Azone or oleic acid at the air-water interface. Int. J. Pharm., 65, 211-218 (1990). https://doi.org/10.1016/0378-5173(90)90145-T
  12. T. Ogiso and M. Shintani, Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propanolol. J. Pharm. Sci., 79, 1065-1076(1990). https://doi.org/10.1002/jps.2600791206
  13. S.C. Shin, C.W. Cho and I.J. Oh, Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int. J. Pharm., 222, 199-203 (2001). https://doi.org/10.1016/S0378-5173(01)00699-8
  14. Z. Gao, W.R. Crowley, A.J. Shukla, J.R. Johnson and J.F. Reger, Controlled release of contraceptive steroids from biodegradable and injectable gel formulations; in vivo evaluation. Pharm. Res., 12, 864-868 (1995). https://doi.org/10.1023/A:1016261004230
  15. A. Lopez, F. Llinares, C. Cortell and M. Herraez, Comparative enhancer effects of span 20 with Tween 20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int. J. Pharm., 202, 133-140 (2000). https://doi.org/10.1016/S0378-5173(00)00427-0
  16. E. Park, S.Y. Chang, M. Hahn and S. Chi, Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int. J. Pharm., 209, 109-210 (2000). https://doi.org/10.1016/S0378-5173(00)00559-7
  17. J. Shokri, A. Nokhodchi, A. Kashbolaghi, K. Hassan-Zadeh, T. Ghafourian and M. Barzegar-Jalali, The effect of surfactants on the skin penetration of diazepam. Int. J. Pharm., 228, 99-107 (2001). https://doi.org/10.1016/S0378-5173(01)00805-5
  18. S.C. Shin, H.J. Kim, I.J. Oh, C.W. Cho and K.H. Yang, Development of tretinoin gels for enhanced transdermal delivery, European J. Pharm. and Biopharm., 60, 67-71 (2005). https://doi.org/10.1016/j.ejpb.2005.01.008
  19. B.W. Barry, Mode of action of penetration enhancers in human skin. J. Cont. Rel., 6, 85-97 (1987). https://doi.org/10.1016/0168-3659(87)90066-6
  20. C.L.L. Saw, P.W.S. Heng, W.W.L. Chin, K.C. Soo and M. Olivo, Enhanced photodynamic activity of hypericin by penetration enhancer N-methyl pyrrolidone formulations in the chick chorioallantoic membrane model. Cancer Letters., 238, 104-110 (2006). https://doi.org/10.1016/j.canlet.2005.06.026